Lipocine 10K 2019 Annual report | LPCN Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: Abady, adult, againstthe, agonist, anemia, answered, antihyperlipidemic, antioxidant, AstraZeneca, atrophy, BeyondJohn, BioPharma, BMI, Boehringer, CAFC, cenicriviroc, Chinese, clock, closure, CMC, Companyfiled, condensed, confirmatory, consecutive, construction, context, CymaBay, DBP, delisted, delisting, diabetic, differentiated, Digestive, dissolve, distinct, Distinguishing, dual, Durect, economy, elafibranor, Enanta, epidemic, eugonadal, fall, fatigue, float, fundamental, FXR, Galectin, Galmed, gemfibrozil, Genfit, Gilead, GmbH, gynecomastia, hair, Hg, Immuron, Ingelheim, InMarch, instrument, intervention, involuntarily, Islet, issuedAccounting, jury, Kidney, LPOCN, Madrigal, MediciNova, Mereo, metformin, MiNA, mixed, mm, NAS, NGM, NIDDK, Nordisk, notification, Novo, NuSirt, ongoingLiFT, outbreak, outlined, paired, pentoxifylline, pioglitazone, portal, PPAR, progesterone, Pugh, quotation, rationale, receivablfe, reclassified, regain, reply, repurchase, SA, sarcopenia, SBP, score, SD, selonsertib, sNDA, Squibb, strain, streamline, strike, Subtopic, testicular, thelift, thePTO, threshold, transplantation, tropifexor, UDCA, ursodeoxycholic, USA, Viking, vitamin, voluntarily, waiting, waived, warranty, wasting, Weface, wefiled, weperformed, wind, worsening, Wuhan, XR

Removed: additive, admixed, algorithm, appointed, area, auditor, batch, captionIn, comprising, conducive, consultant, contraction, counsel, counterpart, discordance, dominate, flexibility, guaranteed, headcount, hydrophilic, hydrophobic, initiative, issuing, judge, LLP, modification, modulator, outsourcing, Pomerantz, prosecuted, recognizing, restructure, retrospective, revaluation, softgel, solid, solubilizer, spend, surfactant, Taiwan, transition, validation

Lipocine (LPCN) 10-K2019 FY Annual report

Content analysis